Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationPanyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Self-citationThe present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Self-citationThe Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
Hidalgo, M., & Rowinsky, E. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204091 · Cited by 582
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Harada, H., Andersen, J. S., Mann, M., Terada, N., & Korsmeyer, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171301998 · Cited by 549
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
Jain, T. K., Richey, J., Strand, M., Leslie-Pelecky, D. L., Flask, C. A., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.004 · Cited by 491
Chan, S., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.66.130 · Cited by 468
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Self-citationHosoi, H., Dilling, M. B., Shikata, T., Liu, L. N., Shu, L., Ashmun, R. A., Germain, G. S., Abraham, R. T., & Houghton, P. J. (1999) · PubMed · Cited by 356
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Self-citationSahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Self-citationKenerson, H. L., Aicher, L. D., True, L. D., & Yeung, R. S. W. (2002) · PubMed · Cited by 315
Determinants of Rapamycin Sensitivity in Breast Cancer Cells
Noh, W.-C., Mondesire, W. H., Peng, J., Jian, W., Zhang, H., Dong, J., Mills, G. B., Hung, M.-C., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0043 · Cited by 285
Park, E. K., Kim, S. Y., Lee, S. B., & Lee, Y. M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.039 · Cited by 239
Huang, S., Shu, L., Dilling, M. B., Easton, J., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216
Suo, Z., Risberg, B., Kalsson, M. G., Willman, K., Tierens, A., Skovlund, E., & Nesland, J. M. (2002) · The Journal of Pathology · doi:10.1002/path.1003 · Cited by 214
Simamora, P., Alvarez, J. M., & Yalkowsky, S. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00617-7 · Cited by 211
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Vega, F., Medeiros, L. J., Leventaki, V., Atwell, C., Cho-Vega, J. H., Tian, L., Claret, F.-X., & Rassidakis, G. Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3018 · Cited by 196
Liu, S.-Q., Wiradharma, N., Gao, S.-J., Tong, Y. W., & Yang, Y.-Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.013 · Cited by 195
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Mundargi, R. C., Srirangarajan, S., Agnihotri, S. A., Patil, S. A., Ravindra, S., Setty, S. B., & Aminabhavi, T. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.008 · Cited by 189
Biological significance of c-erbB family oncogenes in head and neck cancer
Rogers, S. J., Harrington, K. J., Rhys-Evans, P., O-Charoenrat, P., & Eccles, S. A. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5047-1 · Cited by 186
Seufferlein, T., & Rozengurt, E. (1996) · PubMed · Cited by 169
Huang, S., Liu, L. N., Hosoi, H., Dilling, M. B., Shikata, T., & Houghton, P. J. (2001) · PubMed · Cited by 163
Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting
Tseng, C.-L., Wang, T.-W., Dong, G.-C., Yueh-Hsiu Wu, S., Young, T.-H., Shieh, M.-J., Lou, P.-J., & Lin, F.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.006 · Cited by 160
Qaddoumi, M. G., Gukasyan, H. J., Davda, J. P., Labhasetwar, V. D., Kim, K. J., & Lee, V. H. L. (2003) · PubMed · Cited by 160
Muro, S., Cui, X., Gajewski, C., Murciano, J.-C., Muzykantov, V. R., & Koval, M. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00099.2003 · Cited by 153
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.013 · Cited by 152
RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG, CAUSES PROGRAMMED CELL DEATH IN B LYMPHOMA CELLS
Muthukkumar, S., Ramesh, T., & Bondada, S. (1995) · Transplantation · doi:10.1097/00007890-199508000-00010 · Cited by 142
Needleman, P., & Fe, H. (1965) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14716-0 · Cited by 129
Prabha, S., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049970+ · Cited by 127
Peponi, E., Drakos, E., Reyes, G. H., Leventaki, V., Rassidakis, G. Z., & Medeiros, L. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051078 · Cited by 126
Yuan, X., Yuan, Y.-B., Jiang, W., Liu, J., Tian, E.-J., Shun, H.-M., Huang, D., Yuan, X.-Y., Li, H., & Sheng, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.045 · Cited by 125
Ito, D., Fujimoto, K., Mori, T., Kami, K., Koizumi, M., Toyoda, E., Kawaguchi, Y., & Doi, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21532 · Cited by 116
Feng, B., Tomizawa, K., Michiue, H., Miyatake, S., Han, X.-J., Fujimura, A., Seno, M., Kirihata, M., & Matsui, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.010 · Cited by 103
You, J., Li, X., Cui, F. D., Du, Y.-Z., Yuan, H., & Hu, F. Q. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/04/045102 · Cited by 97
Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells
Haddadi, A., Elamanchili, P., Lavasanifar, A., Das, S., Shapiro, J., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31373 · Cited by 94
Praziquantel-loaded PLGA nanoparticles: preparation and characterization
Mainardes, R. M., & Evangelista, R. C. (2005) · Journal of Microencapsulation · doi:10.1080/02652040400026285 · Cited by 86
In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles
Sullivan, C. O., & Birkinshaw, C. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.001 · Cited by 82
The intracellular uptake ability of chitosan-coated Poly (D,L-lactideco-glycolide) nanoparticles
Kim, B., Kim, C.-S., & Lee, K. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1267-5 · Cited by 82
Zweers, M. L. T., Engbers, G. H. M., Grijpma, D. W., & Feijén, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.021 · Cited by 81
Development of bionanocapsules targeting brain tumors
Tsutsui, Y., Tomizawa, K., Nagita, M., Michiue, H., Nishiki, T., Ohmori, I., Seno, M., & Matsui, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.019 · Cited by 75
New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles
Zou, W., Cao, G., Xi, Y., & Zhang, N. (2009) · Drug Delivery · doi:10.1080/10717540802481307 · Cited by 59
Scott, C. J., Marouf, W. M., Quinn, D. J., Buick, R. J., Orr, S. J., Donnelly, R. F., & McCarron, P. A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9400-7 · Cited by 43
Das, S., Haddadi, A., Veniamin, S., & Samuel, J. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31557 · Cited by 37
Cited by
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Self-citation
Metadata
- Authors
- Acharya, S., Dilnawaz, F., & Sahoo, S. K.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 30
- Issue
- 29
- Pages
- 5737-5750
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W1978640331
- Cited by
- 333
- References
- 52
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.